Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEFree Report) in a report issued on Saturday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Up 651.0 %

Shares of NYSE:AMPE opened at $0.08 on Friday. The company has a market cap of $85,614.00, a price-to-earnings ratio of -0.01 and a beta of 3.73. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47.

About Ampio Pharmaceuticals

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

See Also

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.